Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416.
Schuch
Gunter
G
Department of Medicine, University Hospital Hamburg-Eppendorf, University of Hamburg, Germany.
de Wit
Maike
M
Höltje
Jan
J
Laack
Eckart
E
Schilling
Georgia
G
Hossfeld
Dieter K
DK
Fiedler
Walter
W
Scigalla
Paul
P
Jacobs
Mark S
MS
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D001707:Biopsy, Needle; D002528:Cerebellar Neoplasms / Q000175:diagnosis* / Q000601:surgery; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D018325:Hemangioblastoma / Q000175:diagnosis* / Q000601:surgery; D006801:Humans; D007150:Immunohistochemistry; D007211:Indoles / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000601:surgery; D011758:Pyrroles / Q000627:therapeutic use*; D018570:Risk Assessment; D016896:Treatment Outcome; D006623:von Hippel-Lindau Disease / Q000175:diagnosis* / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D007211:Indoles; D011758:Pyrroles; C116890:Semaxinib